Acromegalic Axial Arthropathy: A Clinical Case-Control Study

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 2, 2004, Pages 598-603

  Scarpa, Raffaele ^a   De Brasi, Davide ^a   Pivonello, Rosario ^a   Marzullo, Paolo ^a   Manguso, Francesco ^a   Sodano, Antonio ^a   Oriente, Pasquale ^a   Lombardi, Gaetano ^a   Colao, Annamaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; INSULIN; SOMATOMEDIN BINDING PROTEIN;

ACROMEGALY; ADULT; AGED; ARTHROPATHY; ARTICLE; AXIAL ACROMEGALIC ARTHROPATHY; BODY MASS; BONE DISEASE; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; GLUCOSE TOLERANCE TEST; HUMAN; HYPEROSTOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SPINAL CORD; SPINE MOBILITY; SYMPTOM;

ACROMEGALY; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPEROSTOSIS, DIFFUSE IDIOPATHIC SKELETAL; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPINAL DISEASES; SPINE;

EID: 1442303349     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031283     Document Type: Article

References (32)

1. Melmed S 1990 Acromegaly. N Engl J Med 322:966-977
2. Colao A, Lombardi G 1998 Growth-hormone and prolactin excess. Lancet 352:1455-1461
3. Marie P 1886 Sur deux cas d'acromegalie. Rev Med 6:297-299
4. Colao A, Merola B, Ferone D, Lombardi G 1997 Acromegaly. J Clin Endocrinol Metab 82:2777-2781
5. Barkan A 1997 Acromegalic arthropathy and sleep apnea. J Endocrinol 155(Suppl 9):S41-S44
6. Bluestone R, Bywaters EG, Hartog M, Holt PJ, Hyde S 1971 Acromegalic arthropathy. Ann Rheum Dis 30:243-258
7. Waine H, Bennet GA, Bauer W 1945 Joint disease associated with acromegaly. Am J Med Sci 209:671-678
8. Kellgren JH, Ball J, Tutton GK 1952 The articular and other limb changes in acromegaly. Q J Med 21:405-424
9. Holt P 1981 Locomotor abnormalities in acromegaly. Clin Rheum Dis 7:689-709
10. Johanson NA, Vigorita VJ, Goldman AB, Slavati EA 1983 Acromegalic arthropathy of the hip. Clin Orthop 173:130-139
11. Tornero J, Castaneda S, Vidal J, Herrero-Beaumont G 1990 Differences between radiographic abnormalities of acromegalic arthropathy and those of osteoarthritis. Arthritis Rheum 33:455-456
12. Matteucci BM 1995 Metabolic and endocrine disease and arthritis. Curr Opin Rheumatol 7:356-358
13. Detenbeck LC, Tressler HA, O'Duffy JD, Randall RV 1973 Peripheral joint manifestations of acromegaly. Clin Orthop 91:119-127
14. Lieberman SA, Bjorkengren AG, Hoffman AR 1992 Rheumatologic and skeletal changes in acromegaly. Endocrinol Metab Clin North Am 21:615-631
15. Forgacs SS 1998 Acromegaly. In: Klippel JH, Dieppe PA, eds. Rheumatology. 2nd ed. London: Mosby
16. Sledge CB 1973 Growth hormone and articular cartilage. Fed Proc 32:1503-1505
17. Layton MW, Fudman EJ, Barkan A, Braunstein EM, Fox IH 1988 Acromegalic arthropathy: characteristics and response to therapy. Arthritis Rheum 31:1022-1027
18. Colao A, Marzullo P, Vallone G, Marinò V, Annecchino M, Ferone D, De Brasi D, Scarpa R, Oriente P, Lombardi G 1998 Reversibility of joint thickening in acromegalic patients: an ultrasonography study. J Clin Endocrinol Metab 83:2121-2125
19. Lacks S, Jacobs RP 1986 Acromegalic arthropathy: a reversible rheumatic disease. J Rheumatol 13:634-636
20. Dons RF, Rosselet P, Pastakia B, Doppman J, Gorden P 1988 Arthropathy in acromegalic patients before and after treatment: a long-term follow-up study. Clin Endocrinol 28:515-524
21. Colao A, Marzullo P, Vallone G, Giaccio A, Ferone D, Scarpa R, Rossi E, Smaltino F, Lombardi G 1999 Ultrasonographic evidence of joint thickening reversibility in acromegalic patients treated with lanreotide for 12 months. Clin Endocrinol (Oxf) 51:611-618.
22. Margolis RN, Canalis E, Pertridge NC 1996 Anabolic hormones in bone: basic research and therapeutic potential. J Clin Endocrinol Metab 81:872-877
23. Smythe H, Littlejohn G 1998 Diffuse idiopathic skeletal hyperostosis. In: Klippel JH, Dieppe PA, eds. Rheumatology. 2nd ed. London: Mosby
24. Littlejohn GO, Hall S, Brand CA, Davidson A 1986 New bone formation in acromegaly: pathogenetic implications for diffuse idiopathic skeletal hyperostosis. Clin Exp Rheumatol 4:99-104
25. Julkunen H, Heinonen OP, Knekt P, Maatela J 1975 The epidemiology of hyperostosis of the spine together with its symptoms and related mortality in a general population. Scand J Rheumatol 4:23-27
26. Utsinger PD 1985 Diffuse idiopathic skeletal hyperostosis. Clin Rheum Dis 11:325-351
27. Daragon A, Mejjad O, Czernichow P, Louvel JP, Vittecoq O, Durr A, Le Loet X 1995 Vertebral hyperostosis and diabetes mellitus: a case-control study. Ann Rheum Dis 54:375-378
28. Resnick D, Niwayama G 1976 Radiographic and pathologic features of spinal involvement in diffuse idiopathic skeletal hyperostosis (DISH). Radiology 119:559-568
29. Colao A, Ferone D, Lastoria S, Marzullo P, Cerbone G, Di Sarno A, Longobardi S, Merola B, Salvatore M, Lombardi G 1996 Prediction of efficacy of octreotide therapy in patients with acromegaly. J Clin Endocrinol Metab 81:2356-2362
30. Colao A, Baldelli R, Marzullo P, Ferretti E, Ferone D, Gargiulo P, Petretta M, Tamburrano G, Lombardi G, Liuzzi A 2000 Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. J Clin Endocrinol Metab 85:193-199
31. The DECODE study group on behalf of the European Diabetes Epidemiology Group 1999 Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354:617-621
32. Colao A, Cannavò S, Marzullo P, Pivonello R, Squadrito S, Vallone G, Almoto B, Bichisao E, Trimarchi F, Lombardi G 2003 Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly. Eur J Endocrinol 148:31-38